Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0265-2022

Drug recall · December 8, 2021

5% Dextrose Injection recall

Why: Lack of sterility assurance: bag has the potential to leak.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake Forest, IL 60045 USA, NDC 0409-7100-68/0409-7100-66

Lots / codes

Lot: 4923608 Exp. 1MAY2022

Quantity
765 bags
Company
Pfizer Inc., New York, NY
Distribution
USA Nationwide
Initiated
November 30, 2021 · Voluntary: Firm initiated
Classified
December 2, 2021
Reported
December 8, 2021
Ended
July 12, 2023
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.